Background: This analysis assessed the acquisition (incidence) and persistence (clearance) of human papilloma virus (HPV) infection by self-reported race among men in The HPV in Men (HIM) Study, a multinational prospective study of the natural history of genital HPV infections.
Introduction
Human papilloma virus (HPV) is an established human carcinogen capable of infecting and causing cancer at multiple anatomical sites. HPV infection is highly prevalent among both men and women (1, 2) . With >100 types identified, HPVs are divided into low risk (e.g., HPVs 6, 11, 42, 43, and 44) , that have the potential to induce warts and low-grade squamous intraepithelial lesions, and high risk (e.g., HPVs 16, 18, 31, 33, 35, 45 , 51, 52, and 56) that are causally involved in cervical cancer and cancers at other anatomical sites (3) . For decades we have known that HPV causes cancer in women, but only recently have we recognized that HPV also causes cancer in men (penis, anogenital, and oropharyngeal; ref. 4) , cancers that occur at older ages in men compared to women and cancers for which we have no reliable screening tools. However, most HPV infections are transient and asymptomatic or subclinical, do not result in disease, and are usually selfcleared. Although the quadrivalent HPV vaccine is available for males and females aged 9 to 26 (5) , immunization rates in the United States are low, and the vaccine is not available to those !27 years. Revealing risk factors that may have a role in explaining variations in incidence and persistence of HPV infection may reveal new underpinnings of this infection that can lead to strategies to reduce HPV-related disease.
Previous studies have provided widely varied estimates of HPV prevalence in men ranging from 0% to 73% (1) . Prevalence of genital HPV infection in men seems to vary by world region and to date there is little information on the acquisition (incidence) and persistence (clearance) of HPV infection in men by race. In a previous report (6) , we assessed prevalence of HPV infection by race and observed the lowest HPV prevalence among Asian/Pacific Islanders (PI) even after adjusting for potential confounding factors. Our previous findings were consistent with previous studies that reported a lower prevalence of HPV infection among Asians in Continental Asia (7, 8) . Presently it is unknown why Asian/PI race possesses a lower prevalence of HPV infection but these differences could be attributed to one or more factors including behavioral, socioeconomic, geographic distributions of HPV types, innate genetic differences, or circulating intratypic HPV variants. Building on our previous race-specific HPV prevalence data, the purpose of this analysis was to assess the influence of selfreported race on the incidence and clearance of HPV infections among men in The HPV in Men (HIM) Study. To our knowledge this is the first study to assess the incidence and clearance of genital HPV natural history by race among men.
Materials and Methods

Study population
The HIM study is an on-going prospective, multinational study of the natural history of HPV infection in men (9, 10) . Study inclusion criteria included ages 18 to 70 years and residents of southern Florida in USA, São Paulo in Brazil, or Cuernavaca in Mexico with no plans to relocate within the next 4 years from baseline. Participants also reported no previous diagnosis of genital or anal warts, had not participated in an HPV vaccine study, reported no previous diagnosis of HIV, reported no current penile discharge or burning sensation during urination, were not being treated for sexually transmitted infections, had not been incarcerated during the preceding 6 months, had not been in drug treatment during the preceding 6 months, and were willing to comply with 10 scheduled visits every 6 months for 4 years. The total sample size for this analysis with complete available data was 3,973 men. All study subjects in this analysis completed at least 2 visits. The median number of clinic visits completed was 4 visits and the median interval between visits 6.23 months.
Men were recruited in 3 age groups (18-30 years, 31-44 years, and 45-70 years). In Mexico, men were recruited through a large health plan, from factories and military in Cuernavaca and Morelos. In Brazil, men were recruited through television, radio, and newspaper advertisement, and from a large clinic in São Paulo providing genitourinary services: including tests for HIV and sexually transmitted infections. In the United States, men were recruited mainly from the University of South Florida and the general community in Tampa, Florida. A full description of cohort procedures, HPV prevalence, and factors associated with prevalent infections has already been reported (9, 10) . Men who met all the inclusion criteria reviewed a written informed consent with a trained member who gave the men opportunity to ask questions and decline participation if so desired. The human-subjects' committees of the Ludwig Institute for Cancer Research, São Paulo, Brazil; The Centro de Referencia e Tratamento de Doencas Sexualmente Transmissiveis e AIDS, São Paulo, Brazil; The University of South Florida, USA; and the National Institute of Public Health of Mexico, Cuernavaca, Mexico, approved all study procedures before study initiation. Men who provided consent had a clinical examination 2 weeks before enrollment visit and every 6 months thereafter. Only men who returned for the enrollment visit were included in this study.
Risk factor questionnaire
An extensive 88-item computer-assisted self-interview (CASI) sexual history and health questionnaire were given at enrollment to assess sociodemographic characteristics, and risk factors. The questionnaire required approximately 20 minutes to complete and was written in the region's primary language (Portuguese, Spanish, or English). Self-reported ethnicity was assessed using one question (Hispanic vs. non-Hispanic). For this analysis self-report race was categorized as White, Black, Asian/ PI, Mestizo, or other/mixed race. As expected, the majority of the men (>90%) from the Mexican study site selfidentified as "Mestizo," which represents multiple races (namely White and American Indian), as they recognize the predominance of their "mixed" ancestry unique to Mexico. For this analysis, other/mixed race and Mestizo were combined into a single category: multiple and mixed race.
Data and sample collection/HPV penile and scrotal sampling Samples were obtained from the external genitalia at each visit by use of Dacron (Digene) swabs prewetted with saline. Three separate samples were obtained: corona of glans penis (1 sample), penile shaft (1 sample), and scrotum (1 sample). The samples placed in 450 mL of specimen transport medium, and then combined into one sample before DNA extraction. The specimens were stored at À70 C until PCR analyses and HPV genotyping was conducted. We have previously shown the validity of these 3 anatomical sites in the assessment of HPV status, and high sampling reproducibility for the detection of HPV DNA by use of this method (11) .
DNA extraction and HPV genotyping
DNA extraction was conducted with QIAamp DNA Mini Kit (Qiagen) on a robotic system according to the manufacturer's instructions and DNA was stored at 4 C until use. The extracted DNA samples were tested for the presence of HPV types by amplification of 30 ng of DNA with the PGMY09/11 L1 consensus primer system (12, 13) . HPV genotyping was conducted with the linear array method on all samples irrespective of the HPV PCR result (Roche Molecular Diagnostics). Only samples that tested positive for b-globin (99% at enrollment) were judged to be adequate and included in the analysis. Before genotyping, the amplification products were run on 2% agarose gels to visualize a 450 base pair band corresponding to HPV amplification for identification of samples that might have an HPV type other than the 37 types analyzed in the genotyping assay. Samples for which HPV was amplified on PCR but did not hybridize with a specific HPV type during the genotyping assay (e.g., unclassified infections) were classified as HPV negative. Across the 10 visits, the frequency of these unclassified infections that were classified as HPV negative ranged from 1.25% to 4.0%. The HPV types that were classified as oncogenic were 16 
Statistical analysis
Sociodemographic and sexual behavioral characteristics by race were compared using the Monte Carlo estimation of exact Pearson x 2 test for categorical variables. Time for newly acquired HPV infection for each man was estimated by use of the time from study entry to the date of the first detection of HPV DNA. For estimates of any or type-specific HPV incidence, only participants who were free of any or a specific HPV type, respectively, at enrollment were included.
For grouped incidence analyses, the analytical unit is an individual, so any HPV incidence was defined as a positive test result for at least 1 of 37 HPV genotypes, oncogenic HPV incidence was defined as a positive test for at least one oncogenic HPV type, and non-oncogenic was defined as a positive test for at least one non-oncogenic HPV type. For type-specific and grouped HPV incidence analyses, only the first acquired infection will be considered at a given HPV type or group so the analytical unit is an individual. Cumulative risk of HPV incidence was estimated using the Kaplan-Meier method, with the log-rank tests used to identify differences across race groups. Twelve-month HPV incidence was also estimated using the Kaplan-Meier method. The association between race and HPV incidence was also assessed with Cox proportional hazards regression after adjusting other factors.
HPV clearance was defined as a participant testing HPV negative at 2 consecutive visits after testing positive, excluding infections detected for the first time at a participant's final visit. Men with HPV infections, regardless the infection status at baseline, were included in the clearance analyses. For grouped clearance, the analytical unit is an infection, so each individual genotype was considered as a separate infection. Because men could have been infected with multiple types of HPV within a defined group (e.g., HPV16 and HPV18 are both oncogenic), we adjusted for within-subject correlation in all grouped HPV clearance analyses. The median time to HPV clearance among all men with an incident infection was estimated using the clustered Kaplan-Meier method (15) and men whose infections did not clear were censored in the analysis. To model the associations between race and grouped HPV clearance, we used Cox proportional hazards regression with the robust covariance matrix estimator (16) .
Candidate factors we considered in the multivariable modeling included age (continuous), education, marital status, current smoking status, circumcision, lifetime number of female partners, number of female partners in past 3 to 6 months, lifetime number of male partners, and number of male partners in past 3 to 6 months. The categories of these variables were listed in Table 1 . Backward selection methods were used to select variables in the multivariable models. Age, the design variable, and race were forced to be included in the multivariable models. In addition, as we observed that HPV infection status at baseline had significant impact on HPV clearance, we included this factor in the multivariable models of HPV clearance. We were also interested in evaluating the effect of race on HPV incidence and clearance among those with similar numbers of lifetime female partners; therefore, stratified analysis by lifetime female partners (0-1, 2-9, and 10þ) was conducted. All analyses were conducted with SAS (version 9.3) and tests were twosided with a significance level of 0.05.
Results
Statistically significant differences were observed for the distribution of sociodemographic and sexual behavior characteristics across race (Table 1) . Asian/PI men were younger, less likely to self-report as Hispanic ethnicity, attained a greater number of years of education, were more frequently married and never smokers, and reported the fewest female and male sexual partners. The 12-month incidence of any, oncogenic, and non-oncogenic HPV infection was significantly lower for Asian/PI race and highest for Black race (Table 2 and Fig. 1 ). Incidence for oncogenic HPV types was 18.7% for Asians/PIs, 20.8% for multiple and mixed race, 25.1% for Whites, and 25.4% for Blacks (P < 0.001). Incidence of non-oncogenic types was 18.9% for Asians/PIs, 26.8% for multiple and mixed race, 31.4% for Whites, and 43.2% for Blacks (P < 0.001). Incidence for any HPV infection was 25.0% for Asians/ PIs, 35.2% for multiple and mixed race, 37.3% for Whites, and 45.7% for Blacks (P < 0.001). Although Asian/PI men had the lowest rates of acquisition of new genital infections, once infected the duration of infection was similar to other races (Table 2) .
In multivariable analyses, Asian/PI race was associated with a lower probability of acquiring any (HR ¼ 0.63; 95% CI, 0.42-0.95) and non-oncogenic HPV infection (HR ¼ 0.61; 95% CI, 0.40-0.93) when compared to Whites (HR ¼ 1.0) and marginally associated with oncogenic HPV (HR ¼ 0.72; 95% CI, 0.46-1.13; Table 3 ). There were no statistically significant differences for median duration of infection and clearance by race ( Fig. 2 and Table 3 ). Multiple and mixed race had a lower probability of acquiring nononcogenic infections (HR ¼ 0.83; 95% CI, 0.70-0.98) and borderline associations were observed for any (HR ¼ 0.91; 95% CI, 0.77-1.07) and oncogenic HPV (HR ¼ 0.92; 95% CI, 0.79-1.09; Table 3 ). Moreover, multiple and mixed race Table S1 ): 0 to 1, 2 to 9, and !10 partners. Because of sample size limitations there were few statistically significant results. However, generally Asian/PI race was associated with a lower probability of acquiring any, oncogenic, and non-oncogenic infections across the 3 strata of lifetime number of female partners [e.g., for oncogenic infections; 0 partners: HR ¼ 0.55 (95% CI, 0.31-1.00); 2 to 9 partners: HR ¼ 0.64 (95% CI, 0.33-1.21); !10 partners: HR ¼ 0.45 (95% CI, 0.23-0.88)].
Discussion
The purpose of this analysis is to assess the influence of self-reported race on acquisition (incidence) and persistence (clearance) of HPV infections among men participating in a multinational prospective study. Overall, we observed that self-reported Asian/PI race, compared to other self-reported races, was associated with a lower probability of acquiring an HPV infection, but there were no differences for duration of infection by race. Multiple and mixed race had the second lowest incidence of HPV and exhibited modest rates of new infections compared to the other races and in multivariable models multiple and mixed race was associated with a lower probability of acquiring an infection and with lower probability of clearing an infection.
Previous studies have reported a low prevalence of HPV infection among Asians in Continental Asia (17, 18) and we have shown racial differences in the prevalence of HPV (6) that persisted after adjustment for potential confounding and sexual behavior factors. Specifically, Asian/PI had the lowest HPV prevalence (42.2%) compared to Blacks (66.2%) and Whites (71.5%) and Asian/PI race was associated with a reduced risk HPV infection in multivariable analysis (prevalence ratio ¼ 0.65; 95% CI, 0.52-0.80). The markedly reduced incidence of HPV among Asian/PI in this analysis is consistent with the previously observed lower prevalence of HPV infection among Asian/PIs.
A possible explanation for the observed race-specific differences in HPV infection acquisition could be attributed to race-specific assortative mating. Assortative mating is a nonrandom pattern of mating where individuals with similar traits/phenotypes mate with one another more frequently than what would be expected under a random mating pattern (17) (18) (19) . Thus, if Asian/PI men in our study predominantly mated with Asian/PI, the circulating pool of HPV among each group would be conceivably low. However, because HPV incidence among Asian/PI was relatively consistent when the data were stratified by lifetime sexual partners, differences in innate genetic variations that vary by race or intratypic HPV ancestral types may also explain our findings. Another possible explanation for the observed results in our current analyses could be attributed to potential geographic distribution of HPV types because rates of acquisition and clearance may vary by HPV types, as we do note slight variations in prevalence by country/study site (data not shown) for the most common disease causing HPVs (6, 11, 16, and 18) .
Inherited genetic variations, namely single nucleotide polymorphisms, in gene-disease associations can vary across ethnic and racial groups and there is evidence that such host genetic factors are also involved in HPV infection (20) (21) (22) (23) . Infectious diseases exert selective pressure, and the host genes involved in the immune response are the most numerous and diverse in the human genome, indicating the evolutionary advantages of a varied immunologic response to a wide range of infectious pathogens (24, 25) . The difference in prevalence and incidence of HPV by race in our cohort, which is not fully explained by environmental or behavioral factors, could be attributed to functional diversity of genetically controlled factors including the immune response, inflammation, metabolism, and cell cycle, to name a few (24, 25) . Moreover, small (26) . Previous studies (27) (28) (29) have shown that HLA variants may exhibit a protective role against HPV infection among Asians. Although it is unclear if genetic variations across the racial groups are responsible for our observed race-specific associations, elucidating the possible role of germline variations in host genetics could have clinical relevance by identifying susceptible individuals for infection, clearance, or disease progression. With respect to intratypic HPV ancestral types, previous reports have suggested (30) (31) (32) ) that molecular intratypic variants of HPV subtypes have different geographic and racial distributions and that these intratypic variants seem to modulate risk of viral transmission, persistence, and progression to clinically relevant lesions. Thus, potentially unmeasured intratypic variants in this cohort could explain our findings if a particular race is infected with a unique intratypic variant compared to the other racial groups.
There are many strengths and some limitations of this analysis that should be noted. First, the HIM Study is a unique resource because it is the only multinational prospective study of the natural history of HPV infection in men and this is the first study to assess the incidence and clearance of HPV by race among men. Other strengths of this cohort study are the large sample size, the diversity in behavior and demographics, and study centers in 3 international cities. In this study, we used highly sensitive PCR methods for detection of 37 different HPV types. This method is not only highly sensitive and specific, but allows for relatively rapid evaluation of HPV infection in large epidemiologic studies so that analyses can be completed in a timely manner. However, one of the limitations was the race-specific sample sizes. Specifically, Asian/PI race constitute only 2.8% of the study population whereas Whites made up 45.4% of the study population. Thus, we cannot totally rule out the possibility of selection bias in this study since Asian/PI race was underrepresented and about 80% of the Asian/PI population was from the United States site alone. The Mexican study site did not recruit any Asian/PI men and we acknowledge that the majority of men in the multiple and mixed race category were from Mexico. But, when we analyzed "Mexican race" and "Other race" categories separately, the estimates of effect for both race categories were quite similar for all analyses. Hence, the influence of multiple and mixed race on HPV acquisition and clearance was consistent in our analyses. We also acknowledge that because of collinearity between race and study location we cannot adjust for study location in our models. Another possible limitation is that race was self-reported and we do not possess data on ancestry informative markers to accurately classify our cohort. We also acknowledge that we cannot account for bias due to unmeasured or unknown confounding. Sexual behavior is potentially an important confounder in the association between race and HPV infection. We accounted for potential confounding by adjusting for sexual behavior and we conducted analyses stratified by number of female partners. However, residual confounding still may exist which could potentially inflate the observed point estimates. Of note, there was little evidence of confounding because results were generally consistent between the univariate and multivariable models. Finally, although the overall power of the study is Months Log-rank test: P < 0.0001 Cumulative probability of infection Cumulative probability of infection Cumulative probability of infection Months Log-rank test: P < 0. Any HPV Oncogenic HPV Figure 1 . Incidence of HPV infection by race. Adjusted for age, marital status, total number of female partners, number of female partners in past 3 to 6 months, and number of male partners in past 3 to 6 months.
robust, generalizability of the findings may be limited as participants were not randomly selected. Although there are numerous strengths and some limitations, our results should be interpreted with caution. The mechanisms by which race influences HPV infection natural history among men is unknown. Overall, these results showed that Asian/PI men had the lowest incidence of HPV and exhibited lower probability of acquiring new HPV infections. Multiple and mixed race men had the second lowest incidence of infection and however, whereas they had a lower probability of acquiring HPV, they also had a lower probability of clearing an HPV infection once acquired. 
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